Premium
Gender difference in all‐cause mortality of people living with HIV in Iran: findings from a 20‐year cohort study
Author(s) -
Gheibi Z,
Dianatinasab M,
Haghparast A,
Mirzazadeh A,
Fararouei M
Publication year - 2020
Publication title -
hiv medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.53
H-Index - 79
eISSN - 1468-1293
pISSN - 1464-2662
DOI - 10.1111/hiv.12940
Subject(s) - medicine , cohort , hazard ratio , human immunodeficiency virus (hiv) , hiv diagnosis , demography , mortality rate , hepatitis c , cohort study , antiretroviral therapy , proportional hazards model , viral load , immunology , confidence interval , sociology
Objectives Gender differences in the efficacy of treatment and the mortality of HIV‐infected patients have not yet been fully elucidated. For the first time, we used data from a 20‐year cohort of people living with HIV (PLWH) in four provinces (Fars, Bushehr, Bandar Abbas, and Kohgiluyeh and Boyer‐Ahmad) in the southern part of Iran to assess the gender difference in all‐cause mortality in PLWH in Iran. Methods We analysed data for 1216 patients aged ≥ 15 years who were diagnosed with HIV/AIDS between 1997 and 2017. Three hundred and fourteen (25.8%) were women. Results The death rate from all causes among women was 13.7% vs . 43.8% among men ( P < 0.001). All‐cause mortality was significantly associated with gender [the adjusted hazard ratio (aHR) for men compared with women was 3.20], not being on antiretroviral therapy (ART) compared with being on ART at the last visit (aHR 5.42), older age (aHR 1.03), delayed HIV diagnosis compared with early diagnosis (aHR 1.72), history of incarceration (aHR 1.57), higher log CD4 count at diagnosis (aHR 0.54), and prophylaxis for Pneumocystis pneumonia (aHR 0.09). Conclusions The results of this 20‐year cohort study suggest that gender is an important predictor of survival among HIV‐infected patients. Improving early HIV diagnosis and early ART initiation in men, as well as increased access to hepatitis C virus treatment are needed to increase the survival rate of HIV‐infected patients in Iran.